12-106992962-T-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_004075.5(CRY1):c.1657+3A>C variant causes a splice donor region, intron change. The variant allele was found at a frequency of 0.00438 in 1,614,074 control chromosomes in the GnomAD database, including 41 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as association,risk factor (no stars).
Frequency
Genomes: 𝑓 0.0037 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0044 ( 36 hom. )
Consequence
CRY1
NM_004075.5 splice_donor_region, intron
NM_004075.5 splice_donor_region, intron
Scores
1
1
Splicing: ADA: 0.9984
2
Clinical Significance
Conservation
PhyloP100: 4.18
Genes affected
CRY1 (HGNC:2384): (cryptochrome circadian regulator 1) This gene encodes a flavin adenine dinucleotide-binding protein that is a key component of the circadian core oscillator complex, which regulates the circadian clock. This gene is upregulated by CLOCK/ARNTL heterodimers but then represses this upregulation in a feedback loop using PER/CRY heterodimers to interact with CLOCK/ARNTL. Polymorphisms in this gene have been associated with altered sleep patterns. The encoded protein is widely conserved across plants and animals. Loss of the related gene in mouse results in a shortened circadian cycle in complete darkness. [provided by RefSeq, Jan 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAd4 at 569 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRY1 | NM_004075.5 | c.1657+3A>C | splice_donor_region_variant, intron_variant | ENST00000008527.10 | NP_004066.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CRY1 | ENST00000008527.10 | c.1657+3A>C | splice_donor_region_variant, intron_variant | 1 | NM_004075.5 | ENSP00000008527 | P1 | |||
CRY1 | ENST00000549356.1 | c.217+3A>C | splice_donor_region_variant, intron_variant | 3 | ENSP00000447738 | |||||
CRY1 | ENST00000552790.5 | n.2239A>C | non_coding_transcript_exon_variant | 13/13 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00375 AC: 570AN: 152200Hom.: 5 Cov.: 32
GnomAD3 genomes
AF:
AC:
570
AN:
152200
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00461 AC: 1158AN: 251380Hom.: 7 AF XY: 0.00470 AC XY: 638AN XY: 135870
GnomAD3 exomes
AF:
AC:
1158
AN:
251380
Hom.:
AF XY:
AC XY:
638
AN XY:
135870
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00445 AC: 6502AN: 1461756Hom.: 36 Cov.: 31 AF XY: 0.00457 AC XY: 3321AN XY: 727174
GnomAD4 exome
AF:
AC:
6502
AN:
1461756
Hom.:
Cov.:
31
AF XY:
AC XY:
3321
AN XY:
727174
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00374 AC: 569AN: 152318Hom.: 5 Cov.: 32 AF XY: 0.00388 AC XY: 289AN XY: 74488
GnomAD4 genome
AF:
AC:
569
AN:
152318
Hom.:
Cov.:
32
AF XY:
AC XY:
289
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: association; risk factor
Submissions summary: Other:2
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Delayed sleep phase syndrome, susceptibility to Other:1
risk factor, no assertion criteria provided | literature only | OMIM | May 25, 2017 | - - |
Sleep-wake schedule disorder, delayed phase type;C1263846:Attention deficit hyperactivity disorder Other:1
association, no assertion criteria provided | literature only | Yale Center for Mendelian Genomics, Yale University | Jul 01, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: 3
Find out detailed SpliceAI scores and Pangolin per-transcript scores at